Giant pharmaceutical giant Gilead has announced that it had signed licensing deals with six generic drugmakers to produce and sell its human immunodeficiency virus (HIV) prevention medicine in lower-income countries.

Mia Malan, founder and editor-in-chief of Bhekisisa speaks to POWER Breakfast host Thabiso Tema about the pressure applied to overseas pharmaceuticals  to open lenacapavir to a patent pool that would allow generics to be sold under license in those countries.

Giant pharmaceutical giant Gilead has announced that it had signed licensing deals with six generic drugmakers to produce and sell its human immunodeficiency virus (HIV) prevention medicine in lower-income countries.
Mia Malan, founder and editor-in-chief of Bhekisisa speaks to POWER Breakfast host Thabiso Tema about the pressure applied to overseas pharmaceuticals  to open lenacapavir to a patent pool that would allow generics to be sold under license in those countries.

POWER Breakfast is a fast paced three-hour news and current affairs show, alternating between the latest breaking news, political coverage, analysis, sport, market reports, weather and all your calls. Whether you’re in business, the public service or just want to stay informed, tune in as Thabiso TT Tema connects you to your world.

POWER Breakfast is a fast paced three-hour news and current affairs show, alternating between the latest breaking news, political coverage, analysis, sport, market reports, weather and all your calls. Whether you&rsquo;re in business, the public service or just want to stay informed, tune in as Thabiso TT Tema connects you to your world.

Advertisement